"If our drug works the way it is expected, and I think it will, it will have such a good efficacy and safety profile that we will qualify for one of the fda quicker routes to market."
But it will still have to go through Phase1, 2 and 3 before the “Priority” to market kicks in.
"Designation of a drug as “Priority” does not alter the scientific/medical standard for approval or the quality of evidence necessary.".
Condescending or not you were around the mark with your 10 years from now to when it may hit the market.
Add to My Watchlist
What is My Watchlist?
